A Metaplanet independent director responded to questions about the company’s 10th executive warrant issuance, saying the team purchased the warrants at fair value while Metaplanet’s financial position was uncertain. The investment could result in losses and was not a free grant. The director said focusing only on the exercise price overlooks the amount paid, associated risks, multi-year vesting period, and subsequent lock-up and exercise restrictions.